DENVER – Use of intranasal esketamine with psychotropic medications did not counteract safety and efficacy in treatment for depression, a presenter said at the Anxiety and Depression Association of America annual conference.
“The research is clinically based, reporting a case in which a patient was diagnosed with major depressive disorder and treatment resistant depression and was already on a complex medication list and we’d introduced him to something new,” Mubeena Hanif, MBBS, of the department of psychiatry and behavioral neurosciences at Wayne State University in